Back
Panbela Therapeutics Vs. Checkpoint Therapeutics Industry Stock Comparison
Sell
16
PBLA
Panbela Therapeutics
Last Price:
0.44
Seasonality Move:
-4.94%
Buy
63
CKPT
Checkpoint Therapeutics
Last Price:
1.94
Seasonality Move:
-6.38%
Sell
16
Panbela Therapeutics (PBLA)
is a Sell
Is Panbela Therapeutics a Buy, Sell or Hold?
- The current Panbela Therapeutics [PBLA] share price is $0.40. The Score for PBLA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- PBLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
63
Checkpoint Therapeutics (CKPT)
is a Buy
Is Checkpoint Therapeutics a Buy, Sell or Hold?
- The current Checkpoint Therapeutics [CKPT] share price is $2.03. The Score for CKPT is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- CKPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PBLA Stock Price Chart
What is Panbela Therapeutics's stock price today?
-
The Panbela Therapeutics share price today is $0.40
The current trend is relatively stagnant and PBLA is experiencing selling pressure, which indicates risk of future bearish movement.
CKPT Stock Price Chart
What is Checkpoint Therapeutics's stock price today?
-
The Checkpoint Therapeutics share price today is $2.03
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CKPT is experiencing slight buying pressure.
PBLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 40.99 | Sell |
| Chaikin Money Flow: | -48335 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.39 - 0.47) | Sell |
| Bollinger Bands (100): | (-1.98 - 7.92) | Sell |
CKPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 71.36 | Buy |
| Chaikin Money Flow: | 176025 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.41 - 1.73) | Buy |
| Bollinger Bands (100): | (1.64 - 2.12) | Buy |
PBLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.42 | Sell |
| 20-day SMA: | 0.41 | Sell |
| 50-day SMA: | 0.52 | Sell |
| 200-day SMA: | 11.87 | Sell |
| 8-day EMA: | 0.42 | Sell |
| 20-day EMA: | 0.44 | Sell |
| 50-day EMA: | 1.07 | Sell |
| 200-day EMA: | 647.44 | Sell |
CKPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.69 | Buy |
| 20-day SMA: | 1.57 | Buy |
| 50-day SMA: | 1.74 | Buy |
| 200-day SMA: | 1.98 | Buy |
| 8-day EMA: | 1.75 | Buy |
| 20-day EMA: | 1.67 | Buy |
| 50-day EMA: | 1.73 | Buy |
| 200-day EMA: | 2.37 | Sell |
Panbela Therapeutics Earnings Growth & PBLA Earnings Dates
- Analysts estimate an earnings increase this quarter of $39.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $2,220.22 per share, and an increase next year of $3.68 per share.
Checkpoint Therapeutics Earnings Growth & CKPT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Panbela Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Checkpoint Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||